Hyperferritinemia and inflammation

被引:458
作者
Kernan, Kate F. [1 ,2 ]
Carcillo, Joseph A. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Crit Care Med, 3550 Terrace St, Pittsburgh, PA 15261 USA
[2] Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, Fac Pavil,Suite 2000,4400 Penn Ave, Pittsburgh, PA 15224 USA
关键词
ferritin; hemophagocytic lymphohistiocytosis; hemophagocytosis; iron; macrophage activation; MACROPHAGE ACTIVATION SYNDROME; FERRITIN MESSENGER-RNA; SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; JUVENILE IDIOPATHIC ARTHRITIS; IRON-RESPONSIVE ELEMENT; NECROSIS-FACTOR-ALPHA; ADULT STILLS-DISEASE; HEAVY-CHAIN FERRITIN; HUMAN-SERUM FERRITIN; NF-KAPPA-B;
D O I
10.1093/intimm/dxx031
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Understanding of ferritin biology has traditionally centered on its role in iron storage and homeostasis, with low ferritin levels indicative of deficiency and high levels indicative of primary or secondary hemochromatosis. However, further work has shown that iron, redox biology and inflammation are inexorably linked. During infection, increased ferritin levels represent an important host defense mechanism that deprives bacterial growth of iron and protects immune cell function. It may also be protective, limiting the production of free radicals and mediating immunomodulation. Additionally, hyperferritinemia is a key acute-phase reactants, used by clinicians as an indication for therapeutic intervention, aimed at controlling inflammation in high-risk patients. One school of thought maintains that hyperferritinemia is an ` innocent bystander' biomarker of uncontrolled inflammation that can be used to gauge effectiveness of intervention. Other schools of thought maintain that ferritin induction could be a protective negative regulatory loop. Others maintain that ferritin is a key mediator of immune dysregulation, especially in extreme hyperferritinemia, via direct immune-suppressive and pro-inflammatory effects. There is a clear need for further investigation of the role of ferritin in uncontrolled inflammatory conditions both as a biomarker and mediator of disease because its occurrence identifies patients with high mortality risk and its resolution predicts their improved survival.
引用
收藏
页码:401 / 409
页数:9
相关论文
共 108 条
[1]
INVOLVEMENT OF INTERFERON-GAMMA AND MACROPHAGE-COLONY-STIMULATING FACTOR IN PATHOGENESIS OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS [J].
AKASHI, K ;
HAYASHI, S ;
GONDO, H ;
MIZUNO, S ;
HARADA, M ;
TAMURA, K ;
YAMASAKI, K ;
SHIBUYA, T ;
UIKE, N ;
OKAMURA, T ;
MIYAMOTO, T ;
NIHO, Y .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) :243-250
[2]
ALVAREZHERNANDEZ X, 1989, LAB INVEST, V61, P319
[3]
Macrophage activation syndrome in rheumatic disease: What is the role of the antigen presenting cell? [J].
Behrens, Edward M. .
AUTOIMMUNITY REVIEWS, 2008, 7 (04) :305-308
[4]
Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice [J].
Behrens, Edward M. ;
Canna, Scott W. ;
Slade, Katharine ;
Rao, Sheila ;
Kreiger, Portia A. ;
Paessler, Michele ;
Kambayashi, Taku ;
Koretzky, Gary A. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (06) :2264-2277
[5]
Drug-induced Hypersensitivity Syndrome Clinical and Biologic Disease Patterns in 24 Patients [J].
Ben m'rad, Mona ;
Leclerc-Mercier, Stephanie ;
Blanche, Philippe ;
Franck, Nathalie ;
Rozenberg, Flore ;
Fulla, Yvonne ;
Guesmi, Myriam ;
Rollot, Florence ;
Dehoux, Monique ;
Guillevin, Loic ;
Moachon, Laurence .
MEDICINE, 2009, 88 (03) :131-140
[6]
Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients [J].
Bennett, Tellen D. ;
Hayward, Kristen N. ;
Farris, Reid W. D. ;
Ringold, Sarah ;
Wallace, Carol A. ;
Brogan, Thomas V. .
PEDIATRIC CRITICAL CARE MEDICINE, 2011, 12 (06) :E233-E236
[7]
Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis [J].
Boom, V. ;
Anton, J. ;
Lahdenne, P. ;
Quartier, P. ;
Ravelli, A. ;
Wulffraat, N. M. ;
Vastert, S. J. .
PEDIATRIC RHEUMATOLOGY, 2015, 13
[8]
BROXMEYER HE, 1989, BLOOD, V73, P74
[9]
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition [J].
Canna, Scott W. ;
Girard, Charlotte ;
Malle, Louise ;
de Jesus, Adriana ;
Romberg, Neil ;
Kelsen, Judith ;
Surrey, Lea F. ;
Russo, Pierre ;
Sleight, Andrew ;
Schiffrin, Eduardo ;
Gabay, Cem ;
Goldbach-Mansky, Raphaela ;
Behrens, Edward M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (05) :1698-1701
[10]
A Systemic Inflammation Mortality Risk Assessment Contingency Table for Severe Sepsis [J].
Carcillo, Joseph A. ;
Sward, Katherine ;
Halstead, E. Scott ;
Telford, Russell ;
Jimenez-Bacardi, Adria ;
Shakoory, Bita ;
Simon, Dennis ;
Hall, Mark .
PEDIATRIC CRITICAL CARE MEDICINE, 2017, 18 (02) :143-150